Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038899
Filing Date
2020-08-10
Accepted
2020-08-10 16:02:08
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20200630.htm   iXBRL 10-Q 3349845
2 EX-10.1 aveo-ex101_293.htm EX-10.1 536490
3 EX-31.1 aveo-ex311_9.htm EX-31.1 16534
4 EX-31.2 aveo-ex312_8.htm EX-31.2 16529
5 EX-32.1 aveo-ex321_10.htm EX-32.1 4473
6 EX-32.2 aveo-ex322_11.htm EX-32.2 4464
  Complete submission text file 0001564590-20-038899.txt   13921817

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20200630.xsd EX-101.SCH 74671
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20200630_cal.xml EX-101.CAL 50174
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20200630_def.xml EX-101.DEF 309234
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20200630_lab.xml EX-101.LAB 597494
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20200630_pre.xml EX-101.PRE 461906
12 EXTRACTED XBRL INSTANCE DOCUMENT aveo-10q_20200630_htm.xml XML 2962746
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

EIN.: 043581650 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 201089259
SIC: 2834 Pharmaceutical Preparations